; and (2) by adding at the end the following: (ii) Additional funding (I) In general In addition to the amounts appropriated under clause (i), there is authorized to be appropriated to the Fund $40,000,000 for each of fiscal years 2024 through 2028, which amounts shall be used solely for purposes of carrying out clauses (iii) and (iv) of subsection (c)(4)(D), such amounts to remain available until expended. (II) Restriction on use of funds Any product developed using funding appropriated pursuant to subclause (I) shall be substantially manufactured in the United States. The Secretary may waive the requirements of this subclause with respect to individual entities if the Secretary determines that requiring domestic research and development operations would be inconsistent with the public interest. .